Shares of Northrim BanCorp, Inc. (NASDAQ:NRIM – Get Free Report) hit a new 52-week high during trading on Monday . The stock traded as high as $91.72 and last traded at $91.02, with a volume of 10338 shares changing hands. The stock had previously closed at $88.50.
Northrim BanCorp Price Performance
The company has a market capitalization of $470.64 million, a P/E ratio of 14.71 and a beta of 0.73. The business’s 50-day moving average is $72.52 and its two-hundred day moving average is $64.99. The company has a quick ratio of 0.81, a current ratio of 0.85 and a debt-to-equity ratio of 0.09.
Insider Buying and Selling at Northrim BanCorp
In other Northrim BanCorp news, Director Linda C. Thomas sold 2,550 shares of the company’s stock in a transaction dated Wednesday, November 13th. The stock was sold at an average price of $79.00, for a total value of $201,450.00. Following the transaction, the director now directly owns 1,172 shares in the company, valued at $92,588. This represents a 68.51 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 4.10% of the company’s stock.
Institutional Investors Weigh In On Northrim BanCorp
Northrim BanCorp Company Profile
Northrim BanCorp, Inc operates as the bank holding company for Northrim Bank that provides commercial banking products and services to businesses and professional individuals. It operates through two segments, Community Banking and Home Mortgage Lending. The company offers noninterest-bearing checking accounts and interest-bearing time deposits, checking and savings accounts, individual retirement and money market deposit accounts, certificates of deposit, and business sweep accounts.
Featured Articles
- Five stocks we like better than Northrim BanCorp
- Where to Find Earnings Call Transcripts
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Invest in Blue Chip Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Northrim BanCorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northrim BanCorp and related companies with MarketBeat.com's FREE daily email newsletter.